DK169120B1 - Anvendelse af L-tryptophan og en perifer nedbrydningshæmmer for L-tryptophan til fremstilling af et smertestillende middel - Google Patents

Anvendelse af L-tryptophan og en perifer nedbrydningshæmmer for L-tryptophan til fremstilling af et smertestillende middel Download PDF

Info

Publication number
DK169120B1
DK169120B1 DK452788A DK452788A DK169120B1 DK 169120 B1 DK169120 B1 DK 169120B1 DK 452788 A DK452788 A DK 452788A DK 452788 A DK452788 A DK 452788A DK 169120 B1 DK169120 B1 DK 169120B1
Authority
DK
Denmark
Prior art keywords
tryptophan
pain
peripheral
inhibitor
use according
Prior art date
Application number
DK452788A
Other languages
Danish (da)
English (en)
Other versions
DK452788D0 (da
DK452788A (da
Inventor
Joachim Kamprad
Ludger Rolf
Original Assignee
Joachim Kamprad
Ludger Rolf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Joachim Kamprad, Ludger Rolf filed Critical Joachim Kamprad
Publication of DK452788D0 publication Critical patent/DK452788D0/da
Publication of DK452788A publication Critical patent/DK452788A/da
Application granted granted Critical
Publication of DK169120B1 publication Critical patent/DK169120B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Indole Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK452788A 1986-12-13 1988-08-12 Anvendelse af L-tryptophan og en perifer nedbrydningshæmmer for L-tryptophan til fremstilling af et smertestillende middel DK169120B1 (da)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DE19863642668 DE3642668A1 (de) 1986-12-13 1986-12-13 Schmerzmittel fuer menschen
DE3642668 1986-12-13
PCT/EP1987/000769 WO1988004170A1 (en) 1986-12-13 1987-12-10 Pain-killer
EP8700769 1987-12-10
CA589972 1989-02-02

Publications (3)

Publication Number Publication Date
DK452788D0 DK452788D0 (da) 1988-08-12
DK452788A DK452788A (da) 1988-08-12
DK169120B1 true DK169120B1 (da) 1994-08-22

Family

ID=6316147

Family Applications (1)

Application Number Title Priority Date Filing Date
DK452788A DK169120B1 (da) 1986-12-13 1988-08-12 Anvendelse af L-tryptophan og en perifer nedbrydningshæmmer for L-tryptophan til fremstilling af et smertestillende middel

Country Status (11)

Country Link
US (1) US5216019A (bg)
EP (1) EP0344158B1 (bg)
JP (1) JPH0645539B2 (bg)
KR (1) KR960011235B1 (bg)
AT (1) ATE74505T1 (bg)
AU (1) AU634149B2 (bg)
CA (1) CA1320133C (bg)
DE (2) DE3642668A1 (bg)
DK (1) DK169120B1 (bg)
NO (1) NO882724L (bg)
WO (1) WO1988004170A1 (bg)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102004039196B4 (de) * 2004-08-12 2008-07-31 Dr.Kamprad Kg Neue Formulierung für L-Tryptophan
WO2011056978A2 (en) 2009-11-04 2011-05-12 Trustees Of Boston University S isomers of alpha-methyl hydrocinnamic acid for the treatment of blood disorders
DE102022103658A1 (de) 2022-02-16 2023-08-17 Joachim Kamprad Arzneimittelzusammensetzung enthaltend L-Tryptophan (L-Try) und L-5-Hydroxytryptophan (5-HTP) sowie einen peripheren Abbauhemmer

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4126672A (en) * 1976-02-04 1978-11-21 Hoffmann-La Roche Inc. Sustained release pharmaceutical capsules
US4167558A (en) * 1976-02-13 1979-09-11 Hoffmann-La Roche Inc. Novel sustained release tablet formulations
US4140755A (en) * 1976-02-13 1979-02-20 Hoffmann-La Roche Inc. Sustained release tablet formulations
DE2908127A1 (de) * 1978-03-03 1979-09-06 Merck Patent Gmbh Verwendung von inhibitoren des abbaus von enkephalinen und endorphinen bei der bekaempfung von schmerzzustaenden sowie zur herstellung pharmazeutischer zubereitungen und arzneimittel
JPS57160227A (en) * 1981-03-30 1982-10-02 Fujitsu Ltd Frequency synthesizer
CH652025A5 (de) * 1981-09-14 1985-10-31 Hoffmann La Roche Pharmazeutisches praeparat.
GB2113545A (en) * 1982-01-22 1983-08-10 Mayron International Inc Treatment of migraine
GB2113546A (en) * 1982-01-22 1983-08-10 Mayron International Inc Treatment of migraine
US4639465A (en) * 1985-08-30 1987-01-27 Commonwealth Medical Corporation Of America Method and composition for relieving pain

Also Published As

Publication number Publication date
EP0344158A1 (de) 1989-12-06
EP0344158B1 (de) 1992-04-08
NO882724D0 (no) 1988-06-21
NO882724L (no) 1988-10-10
DK452788D0 (da) 1988-08-12
KR960011235B1 (ko) 1996-08-21
JPH02500746A (ja) 1990-03-15
AU634149B2 (en) 1993-02-18
DK452788A (da) 1988-08-12
US5216019A (en) 1993-06-01
WO1988004170A1 (en) 1988-06-16
DE3778165D1 (bg) 1992-05-14
DE3642668A1 (de) 1988-06-23
KR890700025A (ko) 1989-03-02
AU1042888A (en) 1988-06-30
JPH0645539B2 (ja) 1994-06-15
CA1320133C (en) 1993-07-13
ATE74505T1 (de) 1992-04-15

Similar Documents

Publication Publication Date Title
JP4365107B2 (ja) 医薬組成物
US20230078925A1 (en) Pulsatile drug delivery system for treating morning akinesia
RU2002113921A (ru) Препаративные формы гидрокодона с контролируемым высвобождением
KR20030097892A (ko) 의약 배합제
PT2043637E (pt) Métodos e medicamentos para administração de ibuprofeno
KR20050083827A (ko) 서방성 ｌ-아르기닌 포뮬레이션 및 이의 제조방법 및 용도
LT3119B (en) Pharmaceutical composition and process for the preparation thereof
CN101022795B (zh) L-色氨酸与卡比多巴/苄丝肼的制剂
NZ506020A (en) Use of pharmaceutical combinations containing tramadol and an antiemetic
DK169120B1 (da) Anvendelse af L-tryptophan og en perifer nedbrydningshæmmer for L-tryptophan til fremstilling af et smertestillende middel
US6008222A (en) Method for oral administration of buspirone and nefazodone
US10675269B2 (en) Compositions comprising melatonin
NO20001717L (no) Serotonin-inneholdende formulering for oral administrering og anvendelse av samme
JP2022549833A (ja) 経口速放出性医薬組成物および減量治療の方法
Weiner et al. Dopaminergic antagonism of L‐5‐hydroxytryptophan‐induced myoclonic jumping behavior
CN106177962A (zh) 含沙格雷酯的药物组合物用于治疗或预防脂肪肝、肝纤维化和/或肝损伤的用途
Hinterberger The biochemistry of catecholamines in relation to Parkinson's disease
CN114557992B (zh) 一种复方药物组合物在制备治疗间质性肺炎药物中的应用
WO2009046631A1 (fr) Composition pharmaceutique contenant un inhibiteur d'enzyme de conversion de l'angiotensine et des vitamines b, et son utilisation
CN112915083A (zh) 药物组合物、成套药盒及其应用
US5182285A (en) Cell-protective composition for preventing or treating of peptic ulcer
Fitzpatrick Melatonin in health and disease
BR112021007839A2 (pt) tratamento e prevenção de ejaculação prematura (ep)
RU2270010C2 (ru) Фармацевтическая композиция, обладающая снотворным действием
CN114080221A (zh) 用于减轻疼痛的布洛芬与曲马多的组合

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed

Country of ref document: DK